EB
NVO

Eastern Bank’s Novo Nordisk NVO Stock Holding History

Eastern Bank’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.12M Sell
82,419
-40,164
-33% -$1.85M 0.05% 132
2026
Q2 		$5.88M Sell
122,583
-169,794
-58% -$7.3M 0.09% 115
2026
Q1 		$10.7M Buy
292,377
+210,000
+255% +$9.95M 0.18% 102
2025
Q4 		$4.19M Sell
82,377
-8,891
-10% -$455K 0.07% 114
2025
Q3 		$5.06M Buy
91,268
+1,537
+2% +$90K 0.09% 104
2025
Q2 		$6.19M Hold
89,731
– – 0.12% 100
2025
Q1 		$6.23M Sell
89,731
-719
-0.8% -$59.4K 0.12% 106
2024
Q4 		$7.78M Buy
90,450
+520
+0.6% +$56.2K 0.14% 114
2024
Q3 		$10.7M Buy
+89,930
New +$12M 0.19% 111

Other funds holding NVO

GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return
MCP
Martin Capital Partners Eugene, Oregon $279M AUM 18.87% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EIA
Eastover Investment Advisors Charlotte, North Carolina $257M AUM 14.8% 1-Year Est. Return
NFGCM
Norman Fields Gottscho Capital Management New York $329M AUM 22.06% 1-Year Est. Return
BFA
Benedict Financial Advisors Atlanta, Georgia $504M AUM 20.67% 1-Year Est. Return
HWA
Heartwood Wealth Advisors Richmond, Virginia $1.27B AUM 11.08% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
RI
Ridgewood Investments Springfield, New Jersey $271M AUM
BSB
Bangor Savings Bank Bangor, Maine $1.31B AUM 12.25% 1-Year Est. Return

Eastern Bank's NVO Position: Q3 2026 in Review

Eastern Bank reduced its Novo Nordisk (NVO) stake by 33% in Q3 2026, selling an estimated $1.85M and leaving 82,419 shares worth $3.12M. The position accounts for 0.05% of the portfolio, ranked #132.

Eastern Bank first reported a position in NVO in Q3 2024 and has held it in 9 quarters since. The position peaked at $10.7M in Q1 2026. 64 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • Eastern Bank held 82,419 shares of Novo Nordisk worth $3.12M as of Q3 2026.
  • Eastern Bank sold 40,164 Novo Nordisk shares in Q3 2026, an estimated $1.85M.
  • Novo Nordisk made up 0.05% of Eastern Bank's portfolio in Q3 2026, its #132 holding.
  • Eastern Bank first reported a position in Novo Nordisk in Q3 2024 and has held it in 9 quarters since.
  • Eastern Bank's Novo Nordisk position peaked at $10.7M in Q1 2026.
  • 64 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Eastern Bank's 13F filing for Q3 2026, filed 5 Oct 2026.